2019
DOI: 10.1177/0218492319895840
|View full text |Cite
|
Sign up to set email alerts
|

Noncardiac surgery in patients with a left ventricular assist device

Abstract: Left ventricular assist devices are implanted in patients with chronic left heart failure refractory to maximal medical therapy. These devices were initially meant as bridge-to-transplant therapy, but with technological advances they are now also used as destination therapy. With improved survival, many patients with implanted devices need noncardiac surgery. We present three representative cases of noncardiac surgery in such patients to highlight the issues involved in their management. We also review the con… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
4
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(5 citation statements)
references
References 42 publications
1
4
0
Order By: Relevance
“…Despite these limitations, our study highlights that surgical intervention can be performed safely in this demanding group of patients. Our findings are supported by those of existing studies investigating the outcomes of NCS while on mechanical circulatory support [ 2 , 3 , 8 , 13 , 18 , 21 ]. The prevalence of NCS in LVAD recipients is still increasing, with a growing demand for management of LVAD recipients outside the implanting center and without access to a cardiac surgical team on standby.…”
Section: Discussionsupporting
confidence: 91%
See 1 more Smart Citation
“…Despite these limitations, our study highlights that surgical intervention can be performed safely in this demanding group of patients. Our findings are supported by those of existing studies investigating the outcomes of NCS while on mechanical circulatory support [ 2 , 3 , 8 , 13 , 18 , 21 ]. The prevalence of NCS in LVAD recipients is still increasing, with a growing demand for management of LVAD recipients outside the implanting center and without access to a cardiac surgical team on standby.…”
Section: Discussionsupporting
confidence: 91%
“…Ventricular assist devices (VADs, Table 1 ) were originally introduced in 1990s as bridge to recovery and bridge to cardiac transplantation [ 1 ]. As a consequence of technological advances, left ventricular assist devices (LVADs) are now commonly utilized in patients with chronic left heart failure refractory to maximal medical management as destination therapy [ 2 ]. LVADs have evolved from pulsatile and extracorporeal devices to those implanted within the body to support the circulation with continuous flow provided by an axial (HeartMate II, Abbot, Chicago, IL, USA) or centrifugal (HeartWare HVAD, Medtronic, Dublin, Ireland and HeartMate III, Abbot, Chicago, IL, USA) pump [ 1 ].…”
Section: Introductionmentioning
confidence: 99%
“…In the event of decreased venous return, strategies of placing the patient in a slight Trendelenburg position, judicious fluid loading, and adjusting ventilatory settings are advisable until the recovery of pump preload or vascular tone. [14] Possible hemodynamic effects of intraoperative patient positioning should be considered. Preload can be reduced if the surgical approach requires other than supine position such as reverse Trendelenburg, beach chair, lateral decubitus with one-lung ventilation, or prone positions.…”
Section: Afterload To the Lvadmentioning
confidence: 99%
“…Anesthetic considerations and preparations may vary depending on the type of non-cardiac surgery scheduled for the patient with an LVAD. Because LVADs only function effectively when the left ventricle is adequately filled by the right ventricle, preoperative assessment of right ventricular function, the presence of ventricular tachyarrhythmia, and the degree of pulmonary hypertension are crucial for identifying patients who need invasive monitoring (e.g., central venous catheters, pulmonary artery catheters, or transesophageal echocardiography [TEE]), early initiation of inotropic therapy, or other right ventricular optimization strategies (e.g., judicious volume therapy or ventilator setting adjustments) [ 12 14 ]. To facilitate awareness of any patient-specific or device-specific problems, preoperative discussions with knowledgeable clinicians (e.g., a specialized VAD team, if available) is important [ 12 , 15 ].…”
Section: Preanesthesia Assessmentmentioning
confidence: 99%
See 1 more Smart Citation